Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.65) per share. This is a 71.05 percent decrease over losses of $(0.38) per share from the same period last year.
Caldolor: The Only Non-Opioid Injectable Pain Reliever Approved for Use in Infants, Says FDA
The FDA has approved expanded labeling for Cumberland Pharmaceuticals Inc's (NASDAQ: CPIX) Caldolor, an intravenously delivered formulation of ibuprofen,
